Your trusted source for investing success

Tag: studies

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

 “The opening of this

American Manganese Inc. Updates Lithium Ion Battery Recycling and Discusses Metal Markets

American Manganese Inc. Updates Lithium Ion Battery Recycling and Discusses Metal Markets

Larry W. Reaugh, President and Chief Executive Officer of American Manganese Inc. (TSXV:AMY; PINKS:AMYZF;FRANK:2AM) , is pleased to announce that Kemetco has now completed the successful production of rechargeable lithium ion batteries from recycled Lithium Manganese Oxide (LMO), Lithium Cobalt Oxide (LCO), Lithium Nickel Manganese Cobalt Oxide (NMC) and Lithium Nickel Cobalt Aluminum Oxide

ScoZinc Receives Renewal of Key Operating Permit

ScoZinc Mining Ltd. (TSX VENTURE:SZM) (‘ScoZinc’ or the ‘Company’) is pleased to announce that, as anticipated, the Company has been granted a 10-year renewal of it’s Industrial Approval Permit enabling the restart of operations at the ScoZinc mine in central Nova Scotia. Studies are currently underway to update estimates included

Erdene Continues to Define New Zone North of Midfield; Intersects 120 Metres of 1.14 g/t Gold Including 3 Metres of 33 g/t Gold at Bayan Khundii Gold Project

Erdene Resource Development Corp. (TSX:ERD) (“Erdene” or “Company”) is pleased to announce additional assay results from the Company’s on-going 2017 drill program at its 100%-owned Bayan Khundii Gold Project (“Bayan Khundii”) in southwest Mongolia.

Highlights

High-grade zone continues to be defined between Midfield and Striker Zones with 128 metres of 1.14

Will Trump Bring Back the Gold Standard? Could He?

One thing is for sure, Trump is having a significant impact on the markets. Gold in particular! Get our Report (value of $49) for FREE. Limited time offer. No credit card required.   Get My Free Report
Click here to download for free
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Biotech Stocks on the TSX Year-to-date

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/top-biotech-stocks-tsx/